These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass. Carrel T; Bauer E; Laske A; von Segesser L; Turina M Lancet; 1991 Mar; 337(8742):673. PubMed ID: 1705649 [No Abstract] [Full Text] [Related]
29. Aprotinin versus tranexamic acid: the controversy continues. Levy JH Transfusion; 2006 Mar; 46(3):319-20. PubMed ID: 16533270 [No Abstract] [Full Text] [Related]
30. Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass. Angelini GD; Cooper GJ; Lamarra M; Bryan AJ Lancet; 1990 Mar; 335(8692):799-800. PubMed ID: 1690831 [No Abstract] [Full Text] [Related]
31. Effect of two different dosages of aprotonin on perioperative blood loss during liver transplantation. Ickx B; Pradier O; DeGroote F; Hendrice C; Toungouz M; Vandestadt J; Gelin M; Capel P Semin Thromb Hemost; 1993; 19(3):300-1. PubMed ID: 7689756 [No Abstract] [Full Text] [Related]
32. Intraoperative coronary thrombosis: can aprotinin be incriminated? Royston D J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):137-41. PubMed ID: 7515702 [No Abstract] [Full Text] [Related]
33. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery. Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409 [TBL] [Abstract][Full Text] [Related]
34. [Modification of fibrinolysis of the injured rat brain by local application of aprotinin, hydrogen peroxide and physiologic NaCl solution]. Leheta F; Lenz C; Weichenmeier I; Haas S; Blümel G Med Welt; 1982 Dec; 33(49):1802-4. PubMed ID: 6186889 [No Abstract] [Full Text] [Related]
35. Aprotinin: topical or systemic delivery in left ventricular assist device implantation. Hariawala MD Circulation; 1997 Oct; 96(8):2736-7. PubMed ID: 9355922 [No Abstract] [Full Text] [Related]
36. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273 [TBL] [Abstract][Full Text] [Related]
37. [Dose the administration of low-dose aprotinin contribute to an anti-inflammatory effect in coronary artery bypass grafting?]. Shirasawa B; Hamano K; Gohra H; Katoch T; Fujimura Y; Zempo N; Esato K Kyobu Geka; 1999 Oct; 52(11):943-5. PubMed ID: 10513162 [TBL] [Abstract][Full Text] [Related]
38. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806 [TBL] [Abstract][Full Text] [Related]
39. Coronary artery bypass grafting after aprotinin: are we doing better? Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702 [TBL] [Abstract][Full Text] [Related]
40. Direct complications of sternal re-entry. Muthialu N Asian Cardiovasc Thorac Ann; 2006 Feb; 14(1):90. PubMed ID: 16432134 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]